Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-10-11
2005-10-11
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
06953799
ABSTRACT:
Phthalazine diones that function as intracellular redox modulators and buffers are used to treat stressed cells in various disease states in which the intracellular redox status is impaired. By optimal buffering of aberrant redox states, phthalazine diones enhance the cellular processes essential for survival and augment the conventional or other external therapies necessary for treatment. The phthalazine diones of the invention thus regulate cell growth, differentiation, or death to serve as essential adjunctive therapy for the stressed host in various disease states.
REFERENCES:
patent: 5512573 (1996-04-01), Minin et al.
patent: 5543410 (1996-08-01), Minin et al.
patent: 5633282 (1997-05-01), Collins et al.
patent: 5719151 (1998-02-01), Shall et al.
patent: 5874444 (1999-02-01), West
Teh Merck Index, 11thed. Published by Merck & Co., Inc. (NJ), 1989, pp 463-464, cit.#2922.
Cecil Textbook of Medicine, 21sted., vol. 1, Goldman et al. (eds.), published 2000 by W.B. Saunders Company, pp1060-74.
Stedman's Medical Dictionary, 25thedition, published 1990 by Williams & Wilkins, pp. 435 and 1393.
Ali Abdel-Rahman et al., Disruption of the Blood-Brain Barrier and Neuronal Cell Death in Cingulate Cortex. Dentate Gyrus, Thalamus, and . . . Neurobiology of Disease 10, May 24, 2002, pp. 306-326.
L. Alvarez et al., Dorsal Subthalamotomy for Parkinson's Disease, Movement Disorders, 2001, pp. 72-78, vol. 16, No. 1.
R. A. Armstong et al., The Levels of Neopterin, Biopterin and the Neopterin/Biopterin Ratio in Urine from Control Subjects and Patients with Alzheimer's Disease and Down's Syndrome, Pteridines, 1995, pp. 185-189. vol. 6. No. 4.
Jeffrey S. Armstrong et al., Glutathione Depletion Enforces the Mitochondrial Permeability Transistion and Causes Cell Death in HL60 Cells that Overexpress Bcl-2, The FASEB Journal, Jun. 7, 2002, 18 pages, express article 10.1096/fj.02-0097fje.
Avinash Bhandoola et al., Immature Thymocytes Undergoing Receptor Rearrangements Are Resistant to an Atm-dependent Death Pathway Activated in Mature T Cells by Double-stranded DNA Breaks. The Journal of Experimental Medicine. Sep. 18, 2000, pp. 891-897. vol. 192. No. 6.
Minghua Chen et al., Minocycline Inhibits Caspase-1 and Caspase-3 Expression and Delays Mortality in a Transgenic Mouse Model of Huntington Disease, Nature Medicine, Jul. 2000, pp. 797-801. vol. 6. No. 7.
Terry P. Combs et al., Induction of Adipocyte Complement-Related Protein of 30 Kilodaltons by PPARy Agonists: A Potential Mechanism of Insulin Sensitization, Endocrinology, 2002, pp. 998-1007.
Paola Costantini et al., Oxidation of a Critical Thiol Residue fo the Adenine Nucleotide Translocator Enforces Bcl-2-independent Permeability Transition Pore Opening and Apoptosis, Oncogene, 2000, pp. 307-314.
Paola Costantini et al., Modulation of the Mitochondrial Permeability Transition Pore by Pyridine Nucleotides and Dithiol Oxidation at Two Separate Sites, The Journal of Biological Chemistry, Mar. 22, 1996, pp. 6746-6751, vol. 271, No. 12.
Christophe Crochemore et al., Enhancement of p53 Activity and Inhibition of Neural Cell Proliferation by Glucocorticoid Receptor Activation, The FASEB Journal, Jun. 2002, pp. 761-770, vol. 16.
Martin Crompton et al., Cyclophilin-D Binds Strongly to Complexes of the Voltage-Dependent Anion Channel and the Adenine Nucleotide Translocase to Form the Permeability Transition Pore, European Journal Biochemistry, 1998, pp. 729-735.
Jan De Boer et al., Premature Aging in Mice Deficient in DNA Repair and Transcription, Science, May 17, 2002, pp. 1276-1279, vol. 296.
Francesca De Giorgi et al., The Permeability Transition Pore Signals Apoptosis by Directing Bax Translocation and Multimerization, The FASEB Journal, Feb. 25, 2002, 20 pages. express article 10.1096/fj.01-0269fje.
Thomas Dehmer et al., Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity in Vivo, Journal of Neurochemistry, 2000, pp. 2213-2216, vol. 74, No. 5.
Yair N. Doza et al., Arsenite Blocks Growth Factor Induced Activation of the MAP Kinase Cascade, Upstream of Ras and Downstream of Grb2-Sos, Onocogene, Jul. 1998, pp. 19-24.
Wulf Droge, Free Radicals in the Physiological Control of Cell Function, Physiological Review, Jan. 2002, pp. 47-95, vol. 82.
Yansheng Du et al., Minocycline Prevents Nigrostriatal Dopaminergic Neurodegeneration in the MPTP Model of Parkinson's Disease, Proceedings National Academy Sciences, Dec. 4, 2001, pp. 14669-14674, vol. 98, No. 25.
Anthone W. Dunah et al., Sp I and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease, Science, Jun. 21, 2002, pp. 2238-2243, vol. 296.
Gianluigi Forloni et al., Anti-amyloidogenic Activity of Tetracyclines: Studies In Vitro, Federation of European Biochemical Societies, Dec. 15, 2000, pp. 404-407.
Joachim Fruebis et al., Proteolytic Cleavage Product of 30-kDa Adipocyte Complement-related Protein Increases Fatty-Acid Oxidation in Muscle and Causes Weight Loss in Mice, Proceedings National Academy Sciences, Feb. 13, 2001, pp. 2005-2010, vol. 98, No. 4.
Teruo Hayashi et al., Possible Mechanism of Dantrolene Stabilization of Cultured Neuroblastoma Cell Plasma Membranes, Journal of Neurochemistry, 1994, pp. 1849-1854, vol. 63, No. 5.
Lihua He et al., Hypothesis—Regulated and Unregulated Mitochondrial Permeability Transition Pores: A New Paradigm of Pore Structure and Function?, Federation of European Biochemical Societies, Jan. 4, 2002, pp. 1-7.
Kiichi Hirota et al., AP-I Transcriptional Activity is Regulated by a Direct Association Between Thioredoxin and Ref-1, Proceedings National Academy of Sciences, Apr. 1997, pp. 3633-3638, vol. 94.
Feng Hong et al., Cyclosporine Blocks Muscle Differentiation by Inducing Oxidative Stress and By Inhibiting the Peptidylprolyl-cis-trans-isomerase Activity of Cyclophilin A: Cyclophilin A Protects . . . , The FASEB Journal, Aug. 7, 2002, 24 pages, express article 10.1096/fj.02-0060fje.
Christopher Hug et al., Diabetes, Obesity, and Acrp30/Adiponectin, BioTechniques, 2002, pp. 654-657, vol. 33, No. 3.
Albert Huisman et al., Anti-inflammatory Effects of Tetrahydrobiopterin on Early Rejection in Renal Allografts: Modulation of Inducible Nitric Oxide Synthase, The FASEB Journal, Jul. 2002, pp. 1135-1137. vol. 16.
Rok Humar et al., Hypoxio Enhances Vascular Cell Proliferation and Angiogenesis in Vitro Via Rapamyen (mTOR)-dependent Signaling, The FASEB Journal, Jun. 2002, pp. 771-780, vol. 16.
Shuji Isotani et al., Immunopurified Mammalian Target of Rapamycin Phosphorylates and Activities p70 S6 Kinase a in Vitro, The Journal of Biological Chemistry, No. 26, 1999, pp. 34493-34498, vol. 274, No. 48.
Richard S. Jope et al., AP-I and NF-kB Stimulated by Carbachol in Human Neuroblastoma SH-SY5Y Cells and Differentially Sensitive to Inhibition by Lithium, Molecular Brain Research, May 6, 1997, pp. 171-180.
Nathanael Larochette et al., Rapid Communication - Arsenite Induces Apoptosis Via A Direct Effect on the Mitochondrial Penneability Transition Pore, Experimental Cell Research 1999, pp. 413-421.
Ron Levy et al., Lidocaine and Muscimol Microinjections in Subthalamic Nucleus Reverse Parkinsonian Symptoms, Brain, 2001, pp. 2105-2118.
Gabriel T. Liberatore et al., Inducible Nitric Oxide Synthase Stimulates Dopaminergic Neurodegeneration in the MPTP Model of Parkinson Disease, Nature Medicine, Dec. 1999, pp. 1403-1409, vol. 5, No. 12.
Patricia Limousin et al., Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease, The New England Journal of Medicine, Oct. 15, 1998, pp. 1105-1111.
John L. Lodge et al., Thiol Chelation of Cu2+ by Dihydrolipoic Acid Prevents Human Low Density Lipoprotein Peroxidation, Free Radical Biology & Medicine, 1998, pp. 287-297, vol. 25, No.3.
Jia Luo et al., Subthalamic GAD Gene Therapy in a Parkinson's Disease Rat Model, Science, Oct. 11, 2002, pp. 425-429, vol. 298.
W. S. Lynn et al., Neuroimmunodegeneration: D Neursons and T Cells Use Common Pathways for Cell Death, The FASEB Journal, Sep. 1995, pp. 1147-1156, vol. 9.
W. S. Lynn et al., Possible Control of Cell Death Pat
Henry Mark O.
Lynn William S.
Bach Pharma, Inc.
Henley III Raymond J.
Park J. Andrea
LandOfFree
Modulation of cell fates and activities by diketo phthalazines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of cell fates and activities by diketo phthalazines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of cell fates and activities by diketo phthalazines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3449111